Compounds for the treatment of metabolic disorders United States Patent 07101910

07101910 is referenced by 30 patents and cites 53 patents.

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

Title
Compounds for the treatment of metabolic disorders
Application Number
10/167839
Publication Number
7101910 (B2)
Application Date
June 12, 2002
Publication Date
September 5, 2006
Inventor
Reid W von Borstel
Potomac
MD, US
Shalini Sharma
Gaithersburg
MD, US
Agent
Lewis J Kreisler
Assignee
Wellstat Therapeutics Corporation
MD, US
IPC
A01N 33/24
A01N 33/18
A61K 31/12
A61K 31/235
View Original Source

Citations: 30 (view full list)

  1. Shalini Sharma: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, February 12, 2008: US07329782 (15 worldwide citation)
  2. Kirvin L Hodge, Shalini Sharma, Robert Kaufman, Albert C Lee, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, April 22, 2008: US07361686 (12 worldwide citation)
  3. Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, October 28, 2008: US07442796 (11 worldwide citation)
  4. Kirvin L Hodge, Shalini Sharma, Reid W von Borstel, Stephen D Wolpe: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, April 7, 2009: US07514555 (8 worldwide citation)
  5. Shalini Sharma: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, June 16, 2009: US07547802 (5 worldwide citation)
  6. Kirvin L Hodge, Shalini Sharma, Albert C Lee, Reid W von Borstel: Method for the treatment of metabolic disorders. Wellstat Therapeutics Orporation, Lewis J Kreisler, October 20, 2009: US07605181 (5 worldwide citation)
  7. Kirvin L Hodge, Shalini Sharma, Albert C Lee, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, November 10, 2009: US07615575 (4 worldwide citation)
  8. Shalini Sharma, Reid W von Borstel, Kirvin L Hodge, Michael K Bamat, Stephen D Wolpe: Method for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, December 14, 2010: US07851494 (4 worldwide citation)
  9. Shalini Sharma: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, January 4, 2011: US07863475 (3 worldwide citation)
  10. Kirvin L Hodge, Shalini Sharma, Albert C Lee, Reid W von Borstel: Method for the treatment of metabolic disorders. Wellstat Biologics Corporation, Lewis J Kreisler, April 26, 2011: US07932290 (3 worldwide citation)

References: 53 (view full list)

  1. Toshio Maeda, Masahiro Nomura, Katsuya Awano, Susumu Kinoshita, Hiroya Satoh, Koji Murakami, Masaki Tsunoda: N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same. Kyorin Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, September 7, 1999: US05948803 (41 worldwide citation)
  2. William John Coates, Anthony Maitland Roe, Robert Antony Slater: Pharmaceutical compositions and methods of inhibiting .beta.-adrenergic receptors. Smith Kline & French Laboratories, Joan S Keps, Richard D Foggio, William H Edgerton, March 8, 1977: US04011321 (32 worldwide citation)
  3. Muchowski Joseph Martin, Greenhouse Robert James, Ackrell Jack, Li Tsung Tee, Pfister Jurg Roland: Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use.. Syntex, February 9, 1983: EP0071399-A2 (27 worldwide citation)
  4. Dihydropyridazinones. Smith Kline French Lab, October 12, 1977: GB1488330-A (27 worldwide citation)
  5. Kuramoto Yasuhiro, Okuhira Masayasu, Yatsunami Takashi: Novel quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same.. Wakunaga Seiyaku, October 24, 1990: EP0393400-A1 (26 worldwide citation)
  6. David Edward Thorne, Keith Howard Baggaley, Brian Morgan: Polycyclic oxy-aromatic acid. Beecham Group, Jacobs & Jacobs, July 4, 1978: US04098816 (22 worldwide citation)
  7. Wenderoth Bernd Dr, Sauter Hubert Dr, Roehl Franz Dr, Ammermann Eberhard Dr, Lorenz Gisela Dr: Novel 3-methoxy-imino-propinoic acid esters and fungicides containing them.. BASF, January 16, 1991: EP0407891-A1 (21 worldwide citation)
  8. Kenneth L Kees: Tetrazoles and their use as hypoglycemic agents. American Home Products Corporation, Richard K Jackson, July 4, 1989: US04845231 (19 worldwide citation)
  9. Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff: Endothelin receptor antagonists. Linda E Hall, Stephen A Venetianer, Edward T Lentz, October 6, 1998: US05817693 (19 worldwide citation)
  10. Thomas P Burris, Donald W Combs, Philip J Rybczynski: Biologically active 4H-benzo [1,4]oxazin-3-ones. Ortho McNeil Pharmaceutical, April 29, 2003: US06555536 (17 worldwide citation)